Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01574144 · ClinicalTrials.gov registry record
REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 70
- Enrollment target
NCT01574144: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT01574144 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01574144 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF) Changes in physiologic data are expected to correlate with 30-day readmission rates in this population
Primary Outcome
Percentage of Participants with health care utilizations. Healthcare utilizations include hospitalizations, urgent care visits and emergency department visits.
Interventions
- DEVICE AVIVO™ PiiX Patch Monitor System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-08 |
What the finished NCT01574144 record still lists
NCT01574144 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which AVIVO™ PiiX Patch Monitor System is the first listed.
NCT01574144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01574144 about?
NCT01574144 is a clinical study titled "REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)". The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF) Changes in physiologic data are expected to correlate with 30-day readmission rates in this population
What is the current status of trial NCT01574144?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-04. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01574144?
The interventions under investigation include: AVIVO™ PiiX Patch Monitor System (DEVICE).
Who is sponsoring clinical trial NCT01574144?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia